| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Adam P Robert, Ricardo A Hanel, P David Adelson, Shih-Shan Lang, Paul Grabb, Stephanie Greene, James M Johnston, Jeffrey Leonard, Suresh N Magge, Neena I Marupudi, Joseph Piatt, Rafael De Oliveira Sillero, Edward R Smith, Jodi Smith, Jennifer M Strahle, Sudhakar Vadivelu, John C Wellons, David Wrubel, Asmaa Hatem, Ciarra Moody, Sabrina H Han, Alaa Montaser, Nicklaus Millican, John M Pederson, Aleksandra S Dain, Lauren A Beslow, Philipp R Aldan. Indications for cerebral revascularization for moyamoya syndrome in pediatric sickle cell disease determined by Delphi methodology. Journal of neurosurgery. Pediatrics. 2024-07-19. PMID:39029127. |
cerebral revascularization surgery (crs) has been used to prevent stroke in children with sickle cell disease (scd) and cerebral vasculopathy (e.g., moyamoya syndrome). |
2024-07-19 |
2024-07-22 |
Not clear |
| Abdulhafiz Zakieh, Nicolas Mercure-Corriveau, Sophie Lanzkron, Xinyi Feng, Sonja Vozniak, Elizabeth P Crowe, Herleen Rai, Courtney Lawrence, Denise Bekkouri, Ruchika Goel, Aaron A R Tobian, Evan M Bloc. Chronic automated red cell exchange therapy for sickle cell disease. Transfusion. 2024-07-14. PMID:39003570. |
the data to support chronic automated red cell exchange (rce) in sickle cell disease (scd) outside of stroke prevention, is limited, especially in adults. |
2024-07-14 |
2024-07-16 |
Not clear |
| Paul Muteb Boma, Suzanne Kamin Kisula Ngoy, Jules Mulefu Panda, Bruno Bonnechèr. Empowering sickle cell disease care: the rise of Frontiers in rehabilitation sciences. vol 5. 2024-07-12. PMID:38994332. |
this perspective argues for the rapid creation of specific, cost-effective, technology-supported rehabilitation centres to advance scd care, identify patients at high risk of stroke and implement tailored rehabilitation strategies. |
2024-07-12 |
2024-07-14 |
Not clear |
| Voi Vincenzo, Gutierrez-Valle Victoria, Daniela Cuzzubbo, McMahon Corrina, Maddalena Casale, Maria Del Mar Mañú Pereira, D'Agnolo Mirco, Baba P D Inusa, Mariane de Montalembert, Raffaella Colombatt. Limited access to transcranial Doppler screening and stroke prevention for children with sickle cell disease in Europe: Results of a multinational EuroBloodNet survey. Pediatric blood & cancer. 2024-07-10. PMID:38984411. |
stroke is one of the most devastating complications for children with sickle cell disease (scd). |
2024-07-10 |
2024-07-12 |
Not clear |
| Elizabeth Ormondroyd, Christopher Grace, Wendy Borsari, Anuj Goel, Barbara McDonough, Joel Rose, Christine Seidman, Hugh Watkin. Genetic therapies for cardiomyopathy: survey of attitudes of the patient community for the CureHeart project. European journal of human genetics : EJHG. 2024-07-07. PMID:38972962. |
expressivity is variable and while sometimes mild, complications can result in sudden cardiac death (scd) at any age, heart failure and stroke. |
2024-07-07 |
2024-07-11 |
Not clear |
| Morohuntodun O Oni, Miguel Brito, Chloe Rotman, Natasha M Arche. Genetic Modifiers of Stroke in Patients with Sickle Cell Disease-A Scoping Review. International journal of molecular sciences. vol 25. issue 12. 2024-06-27. PMID:38928024. |
understanding why and in whom stroke is most likely to occur is critical to the effective prevention and treatment of individuals with scd. |
2024-06-27 |
2024-06-29 |
Not clear |
| Preetam Wasnik, Pranita Das, Ajit Kumar, Pankaj K Kannauje, Rohini R, Vinay Pandit, Tarun Sahu, Jyoti Sah. Hospitalization Events Among Adolescents and Adults With Sickle Cell Disease in a Tertiary Care Center in Central India. Cureus. vol 16. issue 5. 2024-06-27. PMID:38933640. |
individuals with scd suffer from both acute and chronic complications, which include recurring episodes of pain commonly called vaso-occlusive crisis (voc) - acute chest syndrome (acs); aseptic necrosis of the bone; micro-infarction of the spleen, brain, and kidney; infections; stroke; and organ damage affecting every part of the body. |
2024-06-27 |
2024-06-29 |
Not clear |
| Jeffrey G Edwards, Adam P Yan, Ramy Yim, Mo Oni, Matthew M Heeney, Dave Johnson, Chris I Wong, Maya Ilowite, Natasha M Arche. Sustained increase in annual transcranial Doppler screening rates in children with sickle cell disease: A quality improvement project. Pediatric blood & cancer. 2024-05-29. PMID:38809385. |
individuals with sickle cell disease (scd) at increased risk for stroke should undergo annual stroke risk assessment using transcranial doppler (tcd) screening between the ages of 2 and 16. |
2024-05-29 |
2024-06-03 |
Not clear |
| Christopher Harden, Hannah Rea, Iris Buchanan-Perry, Beatrice Gee, Alcuin Johnso. A Multidisciplinary Educational Approach for Children With Chronic Illness: An Intervention Case Study. Continuity in education. vol 1. issue 1. 2024-05-23. PMID:38774530. |
a case study on an intervention for a girl with sickle cell disease (scd) and a history of stroke. |
2024-05-23 |
2024-05-27 |
Not clear |
| La'Kita M J Knight, Paula Tanabe, Audrey L Blewer, James Goodrich, Allison A King, Karin Reuter-Rice, Nancy Creg. Association of hydroxyurea adherence with transcranial Doppler screenings in children with sickle cell disease. Pediatric blood & cancer. 2024-05-06. PMID:38706206. |
national sickle cell disease (scd) guidelines recommend oral hydroxyurea (hu) starting at 9 months of age, and annual transcranial doppler (tcd) screenings to identify stroke risk in children aged 2-16 years. |
2024-05-06 |
2024-05-08 |
Not clear |
| Landon C Power, Amy E Mirro, Micahel M Binkley, Jinli Wang, Kristin P Guilliams, Josiah B Lewis, Andria L Ford, Joshua S Shimony, Hongyu An, Jin-Moo Lee, Melanie E Field. Reversibility of Cognitive Deficits and Functional Connectivity With Transfusion in Children With Sickle Cell Disease. Neurology. vol 102. issue 10. 2024-05-06. PMID:38710015. |
people with sickle cell disease (scd) are at risk of cognitive dysfunction independent of stroke. |
2024-05-06 |
2024-05-27 |
Not clear |
| Landon C Power, Amy E Mirro, Micahel M Binkley, Jinli Wang, Kristin P Guilliams, Josiah B Lewis, Andria L Ford, Joshua S Shimony, Hongyu An, Jin-Moo Lee, Melanie E Field. Reversibility of Cognitive Deficits and Functional Connectivity With Transfusion in Children With Sickle Cell Disease. Neurology. vol 102. issue 10. 2024-05-06. PMID:38710015. |
because chronic transfusion therapy is neuroprotective in preventing stroke and strengthening executive function abilities in people with scd, we hypothesized that red blood cell (rbc) transfusion facilitates the acute reversal of disruptions in functional connectivity while white matter integrity remains unaffected. |
2024-05-06 |
2024-05-27 |
Not clear |
| R Sky Jones, Andria L Ford, Manus J Donahue, Slim Fellah, L Taylor Davis, Sumit Pruthi, Charu Balamurugan, Rachel Cohen, Samantha Davis, Michael R Debaun, Adetola A Kassim, Mark Rodeghier, Lori C Jorda. Distribution of Silent Cerebral Infarcts in Adults With Sickle Cell Disease. Neurology. vol 102. issue 10. 2024-04-29. PMID:38684044. |
we tested the hypothesis that adults with sickle cell disease (scd) have silent cerebral infarcts (scis) in the border zone regions, with a secondary hypothesis that older age and traditional stroke risk factors would be associated with infarct occurrence in regions outside the border zones. |
2024-04-29 |
2024-05-03 |
Not clear |
| Aradhana Kumari, Ganesh Chauhan, Partha Kumar Chaudhuri, Sushma Kumari, Anupa Prasa. Genetic Variants Associated with the Risk of Stroke in Sickle Cell Anemia: Systematic Review and Meta-Analysis. Hemoglobin. 2024-04-18. PMID:38637280. |
as it is a rare disease, studies investigating the association with complications like stroke in scd have small sample sizes. |
2024-04-18 |
2024-04-21 |
Not clear |
| Salam Alkindi, Salma Al-Jadidi, Safa Al-Adawi, Refaat Abdullah Elsadek, Ali Al Madhani, Maryam Al-Nabhani, Anil V Pathar. Multi-center study on mortality in children, and adults with sickle cell anemia-risk factors and causes of death. Scientific reports. vol 14. issue 1. 2024-04-13. PMID:38615021. |
scd related complications included acute chest syndrome (acs) in 52.8%, splenic sequestration in 21.1%, right upper quadrant syndrome in 19.5%, more than > 6 voc/year in 17.9%, and stroke in 13.8%. |
2024-04-13 |
2024-04-16 |
Not clear |
| Raizl G Sussman, Joy Mburu, MacGregor Steele, Annie Bang, Jeremy Friedman, Ran Goldman, Melanie Kirby, Margaret L Rand, Victor S Blanchette, Fred G Pluthero, Suzan Williams, Walter H A Kah. Constitutive hypercoagulability in pediatric sickle cell disease patients with hemoglobin SS genotype. Research and practice in thrombosis and haemostasis. vol 8. issue 3. 2024-04-12. PMID:38605827. |
constitutive inflammation and hemostatic activation have been identified as key contributors to the pathophysiology of sickle cell disease (scd), leading to clinical consequences such as vaso-occlusive crises and stroke. |
2024-04-12 |
2024-04-14 |
Not clear |
| Belinda Nestory Moshi, Erick G Philipo, Nancy F Kileo, Joseph Matobo, Emili Yondu, Dionis Ikunda, Daniel Kandonga, Koga M Luhulla, Manase Kilonz. Prevalence of Stroke in Individuals with Sickle Cell Disease Pre- and during Hydroxyurea Uses: A Descriptive Cross-Sectional Study in Tanzania. Advances in hematology. vol 2024. 2024-03-27. PMID:38533292. |
sickle cell disease (scd) is an inherited blood disorder that leads to a variety of complications, including stroke. |
2024-03-27 |
2024-03-29 |
human |
| Belinda Nestory Moshi, Erick G Philipo, Nancy F Kileo, Joseph Matobo, Emili Yondu, Dionis Ikunda, Daniel Kandonga, Koga M Luhulla, Manase Kilonz. Prevalence of Stroke in Individuals with Sickle Cell Disease Pre- and during Hydroxyurea Uses: A Descriptive Cross-Sectional Study in Tanzania. Advances in hematology. vol 2024. 2024-03-27. PMID:38533292. |
the use of hydroxyurea (hu) is reported to lessen the frequency and burden of stroke in scd patients. |
2024-03-27 |
2024-03-29 |
human |
| Belinda Nestory Moshi, Erick G Philipo, Nancy F Kileo, Joseph Matobo, Emili Yondu, Dionis Ikunda, Daniel Kandonga, Koga M Luhulla, Manase Kilonz. Prevalence of Stroke in Individuals with Sickle Cell Disease Pre- and during Hydroxyurea Uses: A Descriptive Cross-Sectional Study in Tanzania. Advances in hematology. vol 2024. 2024-03-27. PMID:38533292. |
however, less is known about the prevalence of stroke in scd patients pre- and during the use of hu in sub-saharan african (ssa) countries. |
2024-03-27 |
2024-03-29 |
human |
| Belinda Nestory Moshi, Erick G Philipo, Nancy F Kileo, Joseph Matobo, Emili Yondu, Dionis Ikunda, Daniel Kandonga, Koga M Luhulla, Manase Kilonz. Prevalence of Stroke in Individuals with Sickle Cell Disease Pre- and during Hydroxyurea Uses: A Descriptive Cross-Sectional Study in Tanzania. Advances in hematology. vol 2024. 2024-03-27. PMID:38533292. |
therefore, the study assessed stroke prevalence before and during uses of hydroxyurea among scd patients in tanzania. |
2024-03-27 |
2024-03-29 |
human |